Back to SYRE

Venrock Adviser, LLC → SYRE

Venrock Adviser, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$221.3M
Q3 2026
Peak value
$265M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$120.7M
Q1 2026$185.9M
Q2 2026$265M
Q3 2026$221.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$221.3M2.49M——
Q2 2026$265M2.99M——
Q1 2026$185.9M3.69M——
Q4 2025$120.7M3.69M——

Other funds holding SYRE

Other Venrock Adviser, LLC positions

APGE

APOGEE THERAPEUTICS INC

$1.1B
APGE

APOGEE THERAPEUTICS INC

$714.9M
APGE

APOGEE THERAPEUTICS INC

$641.1M
ORKA

ORUKA THERAPEUTICS INC

$394.8M
ORKA

ORUKA THERAPEUTICS INC

$345.5M
EQR

ERASCA INC

$327.8M
EQR

ERASCA INC

$294.5M
EQR

ERASCA INC

$265.1M